Zook Anthony P. 4

4 · NEOGENOMICS INC · Filed Mar 3, 2026

AI-generated summary of this filing

Updated Mar 3, 2026

NeoGenomics (NEO) CEO Anthony Zook Receives Equity Awards

What Happened

Anthony P. Zook, CEO of NeoGenomics (NEO), received two equity awards on March 1, 2026: 675,676 stock options and 406,918 restricted stock units (RSUs). These were reported on a Form 4 filed March 3, 2026. The filing shows the derivative awards at $0.00 for reporting purposes (they are grants, not purchases or sales).
The stock options are "premium-price" options — the exercise price for the March 1, 2026 option grant is calculated as the closing price on February 27, 2026 multiplied by 110% (per the filing footnote). The RSUs will convert to common shares when they vest.

Key Details

Transaction date: March 1, 2026 (Form 4 filed March 3, 2026).
Awards granted: 675,676 stock options (derivative); 406,918 RSUs (derivative). Both types are reported as acquisitions (code A).
Vesting: Both the March 1, 2026 options and RSUs vest ratably over the first three anniversaries of the grant date (footnotes F2 and F3). Earlier grants (April 1, 2025) had similar three‑year ratable vesting (footnotes F6–F7).
Exercise price note: The March 1, 2026 option grant is a premium‑price option; exercise price = Feb 27, 2026 closing price × 110% (footnote F1). A prior option grant (4/1/2025) used that date’s close × 110% (F5). The filing does not list a dollar exercise price in the summary lines provided here.
Shares owned after transaction: not specified in the information provided.
Filing timeliness: Form 4 shows report date 3/1/2026 and filing date 3/3/2026; no late‑filing flag was provided in the materials you shared.

Context

These transactions are grants (compensation awards), not purchases or sales — they don't represent an immediate cash investment or cashing out by the insider. Options give the right to buy shares later at an exercise price; RSUs convert to common stock when vested.
Such grants are common elements of executive pay packages and do not, by themselves, indicate a buy or sell signal. For retail investors, purchases by insiders are often a clearer bullish signal; awards primarily reflect company compensation decisions.

Form 4

Period: 2026-03-01

DirectorChief Executive Officer

Transactions

Award
Stock Option (Right to Buy)
[F1][F2]
2026-03-01+675,676→ 675,676 total
Exercise: $10.81Exp: 2036-03-01→ Common Stock (675,676 underlying)
Award
Restricted Stock Unit
[F3][F4]
2026-03-01+406,918→ 406,918 total
Exercise: $0.00→ Common Stock (406,918 underlying)

Holdings

Common Stock
38,066
Common Stock
(indirect: By Trust)
18,900
Stock Option (Right to Buy)
Exercise: $14.82From: 2024-08-10Exp: 2033-08-10→ Common Stock (8,353 underlying)
8,353
Stock Option (Right to Buy)
Exercise: $13.71From: 2025-06-01Exp: 2034-06-01→ Common Stock (8,672 underlying)
8,672
Stock Option (Right to Buy)
[F5][F6]
Exercise: $10.44Exp: 2035-04-01→ Common Stock (729,927 underlying)
729,927
Restricted Stock Unit
[F7][F4]
Exercise: $0.00→ Common Stock (421,496 underlying)
421,496

Footnotes (7)

[F1]This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 27, 2026 and multiplied by 110%.
[F2]On March 1, 2026, Mr. Zook was granted 675,676 stock options. The options vest ratably over the first three anniversary dates of the grant date.
[F3]On March 1, 2026, Mr. Zook was granted 406,918 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
[F4]Once vested, the shares of common stock are not subject to expiration.
[F5]This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on April 1, 2025 and multiplied by 110%.
[F6]On April 1, 2025, Mr. Zook was granted 729,927 stock options. The options vest ratably over the first three anniversary dates of the grant date.
[F7]On April 1, 2025, Mr. Zook was granted 421,496 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.

Signature

/s/ Ali Olivo, Attorney-in-Fact|2026-03-03

1 file